PMID: 7543785Jun 1, 1995Paper

Palliative therapy of melanoma patients with fotemustine. Inverse relationship between tumour load and treatment effectiveness. A multicentre phase II trial of the EORTC-Melanoma Cooperative Group (MCG)

Melanoma Research
U R KleebergM A Lentz

Abstract

Fotemustine (FM) is a new chloronitrosurea (CNU), chemically characterized by the graft of an aminophosphonic acid on the CNU radical, which makes it highly lipophilic. Following single-institution phase I and II studies with remarkably high response rates of some 40%, including brain metastases of 25% and more, the EORTC-MCG started a multicentre phase II trial to confirm these results according to EORTC guidelines. Treatment consisted of an induction cycle of FM (100 mg/m2 on days 1 + 8 + 15), followed by maintenance courses (q3w). Fifty-four patients were entered by 11 institutions. General interest in this promising new agent, however, led clinicians of six additional institutions to join the EORTC trial and 90 more patients were included in only 4 months. This rapidly rising accrual rate became inversely related to the physicians' adherence to the eligibility criteria: palliation of symptoms rather than clinical research was the dominant reason to start treatment. Clinical characteristics and results in the eligible vs non-eligible patient group (in parentheses) were as follows: male/female 29/26 (68/65), mean age 54 years (53), ECOG-PS 0-1 (0-4), CR 2 (0), PR 10 (2), NC 17 (5) and for brain metastases: PR 4 (1), NC 2 (1),...Continue Reading

Citations

Jun 1, 1997·Medical Oncology·J Hansson
Mar 10, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A SeeberH Pehamberger
Apr 13, 2004·Current Opinion in Oncology·Ahmad A Tarhini, Sanjiv S Agarwala
Mar 24, 2011·The Cancer Journal·Mario Sznol
Sep 18, 1997·Journal of Clinical Child Psychology·M J Hoag, G M Burlingame
Oct 31, 2002·Seminars in Oncology·Yan Li, Edward F McClay
Oct 31, 2002·Seminars in Oncology·Emilio BajettaDavid Khayat
Oct 31, 2002·Seminars in Oncology·James G Douglas, Kim Margolin
Nov 15, 2011·Expert Opinion on Pharmacotherapy·Gaëlle Quéreux, Brigitte Dréno
Dec 10, 2003·Mayo Clinic Proceedings·Robert R McWilliamsSvetomir N Markovic
Jul 13, 2004·The Journal of Investigative Dermatology·Nagisa KunikataTadashi Terui
Apr 25, 2006·Surgical Oncology Clinics of North America·David W Ollila, Abigail S Caudle
May 26, 2009·Hematology/oncology Clinics of North America·Arvin S Yang, Paul B Chapman
Dec 4, 2003·Expert Opinion on Pharmacotherapy·Marko B Lens, Tim G Eisen
Feb 7, 2015·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·É Le RhunC Robert
Mar 17, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M F AvrilY Menu
Aug 25, 2004·Cancer Treatment Reviews·D Bafaloukos, H Gogas
Oct 14, 2005·Expert Review of Anticancer Therapy·Robert R McWilliamsJan C Buckner
Jan 4, 2007·Cancer·Helen J GogasVernon K Sondak
Sep 24, 2005·Melanoma Research·Paola QueiroloAlessandro Testori
Sep 24, 2005·Melanoma Research·Lee D CranmerEvan M Hersh
Nov 3, 2006·Expert Review of Neurotherapeutics·Jan Drappatz, Patrick Y Wen
May 13, 2008·Expert Review of Anticancer Therapy·Robert R McWilliamsPaul D Brown
Aug 4, 2007·The Oncologist·April F Eichler, Jay S Loeffler
Nov 20, 2008·Journal of Neuro-oncology·Maria Grazia FabriniLuca Cionini
Sep 27, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Selma UgurelUNKNOWN Dermatologic Cooperative Oncology Group
May 26, 2010·American Journal of Clinical Oncology·Joan Manel Gasent BlesaMariano Provencio Pulla

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.